167 results
SC TO-T
EX-99
PNT
POINT Biopharma Global Inc.
13 Oct 23
Third party tender offer statement
6:52am
line of business or enter into any agreement, arrangement or commitment that materially limits or otherwise restricts POINT or its affiliates (other
SC TO-T
EX-99
SGTX
Sigilon Therapeutics Inc
13 Jul 23
Third party tender offer statement
8:01am
of business or enter into any agreement or commitment that materially limits or otherwise materially restricts Sigilon or its Affiliates, including
SC TO-T
EX-99
hmziw9699 lap
30 Jun 23
Third party tender offer statement
4:06pm
8-K
EX-99.01
mxo0 w01d4acep65opw1
27 Apr 23
Results of Operations and Financial Condition
7:02am
PX14A6G
8mi8d 2lyjpzodmaympq
10 Apr 23
Letter to shareholders
4:51pm
PX14A6G
ep2ubpbjoojal4iz
4 Apr 23
Letter to shareholders
3:57pm
8-K
EX-99.1
2alz75 405hy
1 Nov 22
Lilly Reports Solid Third-Quarter 2022 Financial Results and Continued Pipeline Progress
7:03am
SC TO-C
EX-99.1
sfuttsik4 nq1
18 Oct 22
Information about tender offer
7:02am
8-K
EX-3.2
kw5buaz0 t2i
4 May 22
Material Modifications to Rights of Security Holders
3:04pm
8-K
EX-3.1
t4nxl 0frb3
16 Dec 21
Amendments to Articles of Incorporation or Bylaws
4:04pm
8-K
EX-99.1
fuld094
15 Dec 21
Lilly Highlights Innovation-based Growth Strategy and Pipeline Developments; Announces 2022 Financial Guidance at Investment Community Meeting
7:05am
424B2
okp89mn
10 Sep 21
Prospectus for primary offering
6:07am
424B2
aecfj0j 70t
7 Sep 21
Prospectus for primary offering
6:02am
8-K
EX-99.1
52jcxbcy 84alvf31byc
17 Aug 21
Departure of Directors or Certain Officers
6:50am